Obesity

Latest News

Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose / image credit: ©New Africa/AdobeStock
Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose

September 3rd 2024

Your daily dose of the clinical news you may have missed.

New Findings Underscore Importance of Mental Health Screening in Adolescents Receiving Obesity Treatment / Image credit: ©yuriygolub/AdobeStock
New Findings Underscore Importance of Mental Health Screening in Adolescents Receiving Obesity Treatment

August 28th 2024

Lilly Makes Tirzepatide Single-Dose Vials Available as Self-Pay Option at 50% Discount / image credit Lilly logo  ©MichaelVi/stock.adobe.com
Lilly Makes Tirzepatide Single-Dose Vials Available as Self-Pay Option at 50% Discount

August 27th 2024

Tirzepatide Cuts Risk of Progression to T2D by 94% Over 3 Years in Adults with Obesity, Overweight / image credit blood glucose ©luliia/stock.adobe.com
Tirzepatide Cuts Risk of Progression to T2D by 94% Over 3 Years in Adults with Obesity, Overweight

August 20th 2024

Shifting Trends in GLP-1RA Prescriptions: Daily Dose / image credit: ©New Africa/AdobeStock
Shifting Trends in GLP-1RA Prescriptions: Daily Dose

August 13th 2024

© 2024 MJH Life Sciences

All rights reserved.